MONASHEE INVESTMENT MANAGEMENT LLC
Q2 2026 Form 13-F

BOSTON, MASSACHUSETTS
CIK 0001627608 · CRD 163148 · SEC-registered investment adviser
$59.6M Reported Value Total

MONASHEE INVESTMENT MANAGEMENT, LLC reports 12 total accounts under management (AUM). There are 12 discretionary accounts valued at $1,856,181,965, and 0 non-discretionary accounts.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered Discretionary Manager
Private funds (Form ADV)
5 funds · $239.8M gross asset value
Hedge Fund: $239.8M
Source: Form ADV filed 2026-02-27
Reported value
$59.6M
Quarter over quarter
+26.4%
Holdings
20
Top-10 concentration
65.4%

Filing Structure

Reports holdings for

  • Kiski Partners, LLC (not a 13F filer in our records) · File #028-17388 · Q1 2016 – Q1 2020

Key People

Form ADV owners & control persons
Thomas Joseph Wynn
LIMITED PARTNER
Jeffry Thomas Muller
CHIEF OPERATING OFFICER, CHIEF COMPLIANCE OFFICER
Adam David Schlisman
CHIEF ADMINISTRATION OFFICER, CHIEF FINANCIAL OFFICER

Filing Navigation

13F Metrics

Loading 13F Metrics

Q2 2026 13F record

Q2 2026 13F filing summary

Q2 2026 Form 13F portfolio summary
Period of report June 30, 2026
Filed August 13, 2026
Form 13F-HR
Reported value $59.6M
Positions 20
Change in reported value -67.6%
New positions 21
Exited positions 43
Position turnover 101.6%
Top-10 concentration 65.4%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q2 2026 13F
Filed Aug 13, 2026
20 $59.6M
Q1 2026 13F
Filed May 13, 2026
45 $183.8M
Q4 2025 13F
Filed Feb 12, 2026
39 $177.5M
Q3 2025 13F
Filed Nov 12, 2025
59 $200.5M
Q2 2025 13F
Filed Aug 11, 2025
38 $275.9M
Q1 2025 13F
Filed May 14, 2025
45 $845.1M
Q4 2024 13F
Filed Feb 14, 2025
36 $729.2M
Q3 2024 13F
Filed Nov 12, 2024
107 $923.5M
Q2 2024 13F
Filed Aug 12, 2024
74 $773.4M
Q1 2024 13F
Filed May 14, 2024
101 $845.3M
Q4 2023 13F
Filed Feb 12, 2024
44 $566.5M
Q3 2023 13F
Filed Nov 13, 2023
75 $239.4M
Q2 2023 13F
Filed Aug 10, 2023
68 $418.9M
Q1 2023 13F
Filed May 5, 2023
39 $362.2M
Q4 2022 13F
Filed Feb 9, 2023
27 $232.3M
Q3 2022 13F
Filed Nov 1, 2022
52 $269.6M
Q2 2022 13F
Filed Aug 12, 2022
27 $274.7M
Q1 2022 13F
Filed May 12, 2022
37 $345.3M
Q4 2021 13F
Filed Feb 7, 2022
44 $404.6M
Q3 2021 13F
Filed Nov 9, 2021
262 $541.5M

26 earlier quarters on file — choose one from the quarter menu above.

Top 20 holdings · Q2 2026

Largest Q2 2026 13F positions by reported value
# Holding Reported value % of portfolio
1 GGLAP ALPHABET INC $5.1M 8.54%
2 GGLBP ALPHABET INC $5.0M 8.44%
3 SLDB SOLID BIOSCIENCES INC $5.0M 8.38%
4 DLR DIGITAL RLTY TR INC $4.5M 7.53%
5 SYRE SPYRE THERAPEUTICS INC $4.4M 7.45%
6 ADT ADT INC DEL $3.9M 6.55%
7 TNGX TANGO THERAPEUTICS INC $3.1M 5.25%
8 CELC 0.25 08/01/32 CELCUITY INC $2.8M 4.76%
9 SMCIP SUPER MICRO COMPUTER INC $2.6M 4.36%
10 LEGN LEGEND BIOTECH CORP $2.5M 4.14%
11 GOOGL ALPHABET INC $2.1M 3.6%
12 GOOG ALPHABET INC $2.1M 3.56%
13 QURE UNIQURE NV $2.1M 3.48%
14 INIO INNIO NV $1.9M 3.16%
15 AKR ACADIA RLTY TR $1.8M 3.0%
16 PTRN PATTERN GROUP INC $1.6M 2.71%
17 PCT 4.75 07/01/32 PURECYCLE TECHNOLOGIES INC $1.5M 2.58%
18 MLTX MOONLAKE IMMUNOTHERAPEUTICS $1.5M 2.45%
19 WHK WHITEHAWK MINERALS CORP $1.4M 2.39%
20 TSHA TAYSHA GENE THERAPIES INC $1.4M 2.29%

Values as reported on the Q2 2026 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Similar Managers

Finding Similar Managers

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings